Global Antimicrobial Resistance
Antimicrobial-resistant pathogens arise from the overuse of antimicrobials in humans, agriculture, and the environment, rendering many existing antimicrobial treatments ineffective. The number of annual deaths due to resistant infections will continue to increase, as will the economic and social impacts of drug resistance. Coordinated global action is needed to successfully address the threat of antimicrobial resistance, through new innovation, collaboration, and attention among global health actors and the public.
We are working to bring the science of global strategy to bear on how to achieve the necessary level of global action.
Featured Work
WHO Collaborating Centre on Global Governance of Antimicrobial Resistance
GSL has been designated as the WHO Collaborating Centre on Global Governance of Antimicrobial Resistance. This invitation grew out of GSL’s sustained collaboration with the WHO on issues in AMR governance and policy.
SAFE AMR Governance Partnership
This partnership of world leading social science research centres has come together to develop global governance strategies to tackle AMR. We are bringing together experts in economics, ethics, evaluation, evidence synthesis, gender analysis, law, political science, and veterinary science.
People block – please see right sidebar for options.
Susan Rogers Van Katwyk
Managing Director, AMR Policy Accelerator
Daniela Corno
Project Coordinator
Isaac Weldon
Research Fellow